Cargando…
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer
PURPOSE: Studies comparing the effect of aromatase inhibitor (AI) and tamoxifen use on cardiovascular disease (CVD) risk factors in hormone-receptor positive breast cancer (BC) survivors report conicting results. We examined associations of endocrine therapy use with incident diabetes, dyslipidemia,...
Autores principales: | Rillamas-Sun, Eileen, Kwan, Marilyn L., Carlos, California, Cheng, Richard, Neugebauer, Romain, Rana, Jamal S., Nguyen-Huynh, Mai, Shi, Zaixing, Laurent, Cecile A., Lee, Valerie S., Roh, Janise M., Huang, Yuhan, Shen, Hanjie, Hershman, Dawn L., Kushi, Lawrence H., Greenlee, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055634/ https://www.ncbi.nlm.nih.gov/pubmed/36993531 http://dx.doi.org/10.21203/rs.3.rs-2675372/v1 |
Ejemplares similares
-
Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study
por: Greenlee, Heather, et al.
Publicado: (2014) -
Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy
por: Lo, Joan C., et al.
Publicado: (2021) -
Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
por: Kwan, Marilyn L., et al.
Publicado: (2014) -
Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study
por: Anyene, Ijeamaka C., et al.
Publicado: (2021) -
Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables
por: Wang, Zinian, et al.
Publicado: (2020)